Pharma jobs in Switzerland 2026: Roche, Novartis, and the life sciences cluster
Switzerland hosts the global headquarters of two of the world's three largest pharmaceutical companies (Roche and Novartis, both in Basel) along with a deep ecosystem of mid size and emerging biotech firms across the Basel, Zurich, and Arc Lémanique clusters. The sector employs over 50,000 people directly in Switzerland and represents the country's highest value export industry. For scientists, regulatory professionals, and commercial specialists targeting an international career in life sciences, Switzerland, and Basel in particular, is among the most strategically significant job markets in the world.
- Research Scientist / Postdoc (Roche, Novartis): CHF 90,000–120,000
- Senior Scientist / Group Leader: CHF 120,000–165,000
- Regulatory Affairs Manager (5 years exp.): CHF 110,000–150,000
- Clinical Trial Manager: CHF 100,000–140,000
- Quality Assurance Manager: CHF 100,000–135,000
- Medical Affairs Director: CHF 170,000–240,000
- Commercial Director (Switzerland): CHF 180,000–270,000
The Swiss pharma clusters: where the jobs are
Basel is the global capital of the Swiss pharma industry. Roche (approximately 15,000 employees in Basel, global HQ) and Novartis (approximately 12,000 in Basel, global HQ) dominate, but the cluster includes Johnson & Johnson, Syngenta, CIBA (now part of BASF), Lonza, and dozens of biotech companies. Basel operates as a single labour market with the German and French border regions: many professionals live across the border and commute into Basel daily.
Arc Lémanique (Vaud): Nestlé Research (Lausanne), Ferring Pharmaceuticals (Saint Prex), Debiopharm (Lausanne), Lonza (headquarters in Basel, key operations in Viège VS), and a growing cluster of biotech scale ups emerging from EPFL and UNIL. The Biopôle campus in Lausanne Épalinges is Switzerland's largest life sciences campus outside Basel and is a significant hiring hub.
Zurich: Roche diagnostic division, Lonza headquarters, Bachem, and an active biotech startup ecosystem anchored by ETHZ spin offs. Less dominant than Basel for pharma, but significant for medtech and diagnostics.
What roles are in demand
The highest demand specialisations in Swiss pharma as of 2026 are: regulatory affairs (particularly for EU and US market access: EMA/FDA experience is premium); clinical operations (CRA, CTM, data management: persistent global shortage); quality assurance and GMP compliance (critical for manufacturing sites); bioinformatics and computational biology (AI driven drug discovery is a priority investment area); medical writing; and market access and health economics (increasingly important as payers require evidence dossiers). Researchers with PhD backgrounds in oncology, immunology, and rare diseases are particularly sought at Roche and Novartis given their pipeline concentrations.
Hiring process at Roche and Novartis
Both Roche and Novartis use structured, multi stage processes. Initial application via their career portal ([roche.com/careers](https://roche.com/careers), [novartis.com/careers](https://novartis.com/careers)) is screened by HR, then the hiring manager. Phone/video screens are followed by 2 to 4 rounds of panel interviews mixing technical, behavioural, and case components. For senior roles, a presentation on a relevant topic is common. The process typically takes 6 to 12 weeks from application to offer. Referrals from internal employees significantly accelerate screening: LinkedIn connections at Roche or Novartis are worth activating before applying.
Both companies operate English as their internal language for most scientific and managerial functions, making them accessible to anglophones. For Swiss market commercial roles (sales, medical liaison), French or German depending on the region may be required.
Work permits for pharma roles
Switzerland's quota system for non EU workers applies in pharma as elsewhere, but major employers like Roche and Novartis have experienced HR departments that routinely sponsor non EU professionals for specialised roles. For PhD level scientists, regulatory specialists, and clinical data professionals with rare expertise, the quota process is navigable with an employer's full support. EU nationals face no quota restrictions and can be hired and onboarded within 3 months.
Frequently asked questions
Do I need to speak German to work in pharma in Basel?
For scientific and managerial roles at Roche and Novartis: no, English is the internal language for most functions. For roles with significant local market interaction (Swiss sales, patient affairs, local medical liaison), German (B2 minimum) is often required. Daily life in Basel, and integration beyond the office, is substantially easier with German: Basel is a German speaking city with a French speaking region just across the border.
Is it better to target Roche or Novartis?
Both are excellent employers with strong internal mobility and competitive compensation. Roche is more diagnostics focused alongside its pharma operations; Novartis is more focused on innovative medicines and generics (through former Sandoz, now independent). Culture differs: Roche is often described as slightly more informal and science driven; Novartis as more globally standardised and commercially oriented. The best choice depends on your specific role, therapeutic area, and career trajectory. Applying to both simultaneously is standard practice.
What qualifications are required for a regulatory affairs role in Switzerland?
A life sciences degree (pharmacy, biochemistry, biology, medicine) is standard. Experience with EMA, FDA, or Swissmedic regulatory dossiers is valued. Certifications such as the TOPRA diploma (MSc in Regulatory Affairs) are well regarded. For senior roles at Roche or Novartis, 5 to 8 years of regulatory experience in a similar size organisation or CRO is typically required. Language skills: English essential, French or German a significant advantage for roles with Swiss or European market access responsibilities.